Ohashi T - Search Results

1

Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.

Furukawa K, Ohashi T, Haruki K, Fujiwara Y, Iida T, Shiba H, Uwagawa T, Kobayashi H, Yanaga K. Furukawa K, et al. Among authors: ohashi t. Cancer Lett. 2011 Jul 1;306(1):92-8. doi: 10.1016/j.canlet.2011.02.036. Epub 2011 Apr 8. Cancer Lett. 2011. PMID: 21482023

2

Inflamed glomeruli-specific gene activation that uses recombinant adenovirus with the Cre/loxP system.

Yokoo T, Ohashi T, Utsunomiya Y, Shiba H, Shen JS, Hisada Y, Eto Y, Kawamura T, Hosoya T. Yokoo T, et al. Among authors: ohashi t. J Am Soc Nephrol. 2001 Nov;12(11):2330-2337. doi: 10.1681/ASN.V12112330. J Am Soc Nephrol. 2001. PMID: 11675409

3

Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector.

Kimura T, Ohashi T, Kikuchi T, Kiyota H, Eto Y, Ohishi Y. Kimura T, et al. Among authors: ohashi t. Cancer Gene Ther. 2003 Nov;10(11):833-9. doi: 10.1038/sj.cgt.7700627. Cancer Gene Ther. 2003. PMID: 14605669

4

NF-kappaB prevents TNF-alpha-induced apoptosis in an oligodendrocyte cell line.

Hamanoue M, Yoshioka A, Ohashi T, Eto Y, Takamatsu K. Hamanoue M, et al. Among authors: ohashi t. Neurochem Res. 2004 Aug;29(8):1571-6. doi: 10.1023/b:nere.0000029571.39497.56. Neurochem Res. 2004. PMID: 15260136

5

Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats.

Shiba H, Okamoto T, Futagawa Y, Misawa T, Yanaga K, Ohashi T, Eto Y. Shiba H, et al. Among authors: ohashi t. J Surg Res. 2006 Jun 15;133(2):193-6. doi: 10.1016/j.jss.2005.10.023. J Surg Res. 2006. PMID: 16730258

6

Adenovirus vector-mediated gene therapy using iodized oil esters for hepatocellular carcinoma in rats.

Shiba H, Misawa T, Iida T, Okamoto T, Futagawa Y, Sakurai M, Ohashi T, Eto Y, Yanaga K. Shiba H, et al. Among authors: ohashi t. Anticancer Res. 2008 Jan-Feb;28(1A):51-3. Anticancer Res. 2008. PMID: 18383824 Free article.

7

Adenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma.

Iida T, Shiba H, Misawa T, Ohashi T, Eto Y, Yanaga K. Iida T, et al. Among authors: ohashi t. Cancer Sci. 2008 Oct;99(10):2097-103. doi: 10.1111/j.1349-7006.2008.00953.x. Cancer Sci. 2008. PMID: 19016771 Free PMC article.

8

Immunogene therapy by adenovirus vector expressing CD40 ligand for metastatic liver cancer in rats.

Hanyu K, Iida T, Shiba H, Ohashi T, Eto Y, Yanaga K. Hanyu K, et al. Among authors: ohashi t. Anticancer Res. 2008 Sep-Oct;28(5A):2785-9. Anticancer Res. 2008. PMID: 19035311 Free article.

9

A novel approach for gene transduction with adenovirus vector and the fibrin glue system.

Sakurai M, Misawa T, Shiba H, Iida T, Ohashi T, Yanaga K. Sakurai M, et al. Among authors: ohashi t. Anticancer Res. 2008 Nov-Dec;28(6A):3809-13. Anticancer Res. 2008. PMID: 19189668 Free article.

10

Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case.

Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T, Ijima M, Fujiwara M, Kaneshiro E, Ohashi T, Eto Y, Ishigaki K, Osawa M, Kyosen SO, Ida H. Kobayashi H, et al. Among authors: ohashi t. Mol Genet Metab. 2010 May;100(1):14-9. doi: 10.1016/j.ymgme.2010.01.015. Epub 2010 Feb 4. Mol Genet Metab. 2010. PMID: 20202878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,495 results

Search Page

Filters